CHENGDU, China, June 3, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 American Society...
WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June:
Verified Market Research® Reports Rising Adoption Across Personal Care, Household Cleaning, Industrial Cleaning, and Agrochemical Formulations as Manufacturers Prioritize Foam Stability, Cleansing Performance, Formulation...
Verified Market Research® Reports Rising Adoption Across Personal Care, Household Cleaning, Industrial Cleaning, and Agrochemical Formulations as Manufacturers Prioritize Foam Stability, Cleansing Performance, Formulation...
Heron Power, a U.S.-based manufacturer of next-generation medium-voltage power electronics, today announced a collaboration with LG Energy Solution Vertech
CANNES, France, June 2, 2026 /PRNewswire/ -- Ampace is exhibiting at Datacloud Global Congress 2026 (Booth 301, Palais -1 Hall, Cannes) this week, presenting...
Positive Results from Phase 2a Clinical TrialStudy met its primary endpoint demonstrating safety and tolerability of ifetroban in patients with high-risk solid tumorsTrial revealed promising...
SYDNEY, June 2, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia," "Kazia Therapeutics" or the "Company"), a clinical-stage oncology company advancing therapies designed...
TAIPEI, June 2, 2026 /PRNewswire/ -- Recharge Power (7921-TW), a pioneer and market leader in Taiwan's battery energy storage systems (BESS) industry, today announced...
TAIPEI, June 2, 2026 /PRNewswire/ -- Solid State Storage Technology Corporation (SSSTC), a subsidiary of Kioxia Corporation and a leading global SSD provider, is...
In the news release, Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic...